Publication Now Available from the HCC Experts Round Table (Americas & Europe)

This peer-reviewed article from interdisciplinary experts describes the impact of the IMbrave150 trial on treating advanced hepatocellular carcinoma.

The HCC Experts Round Table (Americas & Europe) brought together international experts in hepatocellular carcinoma, from fields including oncology, hepatology, radiology, patient advocacy, and health economics. The HCC Experts Round Table has recently published their assessment of the impact of the IMbrave150 trial on standards of care for advanced first-line HCC.

Watch the video overview from manuscript senior author Prof. Peter Galle and download your educational slides, summarizing the conclusions of the HCC Experts Round Table in their peer-reviewed publication. This educational content is relevant for all clinical team members involved in the care of advanced HCC.

Kulik L, da Fonseca LG, He AR, Rimola J, Wilson Woods A, Zöllner YF, Galle PR. Potential Impact of IMbrave150 Results in the Evolving Treatment Landscape of Advanced Hepatocellular Carcinoma: A Multidisciplinary Expert Opinion. J Hepatocell Carcinoma. 2020;7:423

This educational programme is supported by an Independent Educational Grant from Roche.